Table 2.
Authors | Patients (n) | Adverse events*, n | Additional treatment |
---|---|---|---|
Inoue et al. [13] | 17 | 1 pneumoperitoneum | Veress needle |
| |||
Swanström et al. [14] | 5 | 2 small perforations in gastric cardia 3 capnoperitoneum |
Endoscopic clips Veress needle |
| |||
von Renteln et al. [15] | 16 | 6 minor cutaneous emphysema 8 capnoperitoneum treated with Veress needle 1 small perforation at GEJ, treated with endoscopic clips |
Veress needle Endoscopic clips |
| |||
Costamagna et al. [16] | 11 | 2 small perforations at junctional flap Asymptomatic pneumomediastinum in all patients 2 transient cervical emphysema |
Endoscopic clips |
| |||
Chiu et al. [17] | 16 | 1 aspiration pneumonia 2 transient cervical emphysema |
Hospital admission and monitoring |
| |||
Hungness et al. [21] | 18 | 7 capnoperitoneum 1 contained perforation at the EGJ |
Veress needle |
| |||
Ren et al. [25] | 119 | 66 subcutaneous emphysema 30 pneumothorax 35 mediastinal emphysema 1 delayed hemorrhage 58 pleural effusions 59 inflammations/atelectases of the lungs 47 aeroperitonea |
|
| |||
Zhou et al. [24] | 12 | 1 small perforation at GEJ, treated with endoscopic clips 3 capnoperitoneum, one treated with Veress needle 4 pneumothorax, one treated with thoracic tube 4 mediastinal emphysema 2 subcutaneous emphysema |
Endoscopic clips Veress needle Thoracic tube |
| |||
Verlaan et al. [18] | 10 | No complications reported | None |
| |||
Minami et al. [20] | 28 | 1 perforation at GEJ, treated with endoscopic clips 2 postoperative bleedings |
Endoscopic clips |
| |||
Lee et al. [19] | 13 | No complications reported | None |
| |||
Von Renteln et al. [22] | 70 | 3 clip dislocation at mucosal closure 1 perforation at mucosal entry site 3 mucosal injuries 1 bleeding requiring intervention 1 cap detached in submucosal tunnel 1 delayed bleeding (hematoma) |
Endoscopic reclipping Endoscopic clips Endoscopic clips Endoscopic hemostasis Endoscopic removal Hospital admission and monitoring |
*includes all reported outcomes, including nonclinically significant and asymptomatic adverse events.